Symptoms of Anxiety and Risk of Coronary Heart Disease
The Normative Aging Study Ichiro Kawachi, MD; David Sparrow, DSc; Pantel S. Vokonas, MD; Scott T. Weiss, MD Background Several studies have suggested an increased risk of fatal coronary heart disease (CHD) among patients with panic disorder, phobic anxiety, and other anxiety disorders. We prospectively examined this association in the Normative Aging Study.
Methods and Results An anxiety symptoms scale was constructed out of five items from the Cornell Medical Index, which was administered to the cohort at baseline. During 32 years of follow-up, we observed 402 cases of incident coronary heart disease (137 cases of nonfatal myocardial infarction, 134 cases of angina pectoris, and 131 cases of fatal CHD -made up of 26 cases of sudden cardiac death and 105 cases of nonsudden death). A nested case-control design (involving 1869 control subjects who remained free of diagnosed CHD) was S everal studies have suggested that chronic anxiety is associated with an increased risk of coronary heart disease. [1] [2] [3] Recently, two prospective cohort studies have found a strong association between self-reported symptoms of phobic anxiety and risk of fatal coronary heart disease (CHD).4.5 In the Northwick Park Heart Study,4 an ongoing cohort of 1457 British men, high levels of anxiety were associated with relative risks of fatal CHD of 3.77 (95% confidence interval [CI]: 1.64 to 8.64 ). In that study, the presence of anxiety was assessed using the Crown-Crisp index,6 an 8-item self-rated scale that elicits common symptoms of phobic anxiety. Using the same index of phobic anxiety, Kawa 15.73 ).
The postulated mechanisms through which anxiety may increase the risk of fatal CHD include hyperventilation during an acute attack, which could in turn induce coronary spasm,7 or an acute attack of anxiety triggering an episode of fatal ventricular arrhythmias. 8, 9 In the present study, we examined the association between symptoms of anxiety and risk of coronary heart disease in the Normative Aging Study, an ongoing prospective cohort study.
Methods
The Normative Aging Study is a longitudinal study of aging established by the Veteran Administration in 1961. 10 The study cohort consists of 2280 community-dwelling men from the Greater Boston area who were aged 21 to 80 years at the time of entry. Volunteers were screened at entry according to health criteria,10 and were free of known chronic medical conditions at the start of follow-up.
Assessment of Exposures
In the first phase of screening, the Cornell Medical Index1" was administered to all participants. We constructed a fiveitem anxiety symptom scale out of questions selected from the Cornell Medical Index. The five individual items selected were similar to items included in existing, validated psychological assessment scales, such as the Brief Symptom Inventory,12 the Spielberger State-Trait Anxiety Inventory,13 the Hamilton Rating Scale for Anxiety,14 and the Crown-Crisp index. 6 We selected the following five items to construct our anxiety scale: "Do strange people or places make you afraid?"; "Are you considered a nervous person?"; "Are you constantly keyed up and jittery?"; "Do you often become suddenly scared for no good reason?"; and "Do you often break out in a cold sweat?" The items were selected in an a priori manner, i.e., before any analyses had been carried out. A positive response to any of these questions scored 1, while a negative response scored 0. Our anxiety symptom scale therefore ranged from 0 to 5, with higher scores indicating higher levels of anxiety. For the purposes of analysis, we categorized responses to our anxiety scale into scores of 0, 1, and 2 or more. These cut-points were arrived at from an a priori categorization of scores, based on an assessment of the score distribution in the whole cohort (in which 89.3% scored 0, 8.8% scored 1, and 1.9% scored 2 or more).
We assessed the validity of the scale we constructed against the Crown-Crisp experiential index,6 which was the instrument used in the two previous prospective studies that suggested an association between anxiety and fatal coronary heart disease (ie, the Northwick Park Heart Study4 and the Health Professionals Follow-up Study5). The Crown-Crisp index is an eightitem questionnaire, with possible scores ranging from 0 (no symptoms of phobic anxiety) to a maximum of 16 
Measurement of Other Cardiovascular Risk Factors
The baseline examination in the Normative Aging Study also included a medical history, physical examination, and a variety of biochemical laboratory tests. Serum cholesterol was measured with the calorimetric method of Sperry.'5 Blood pressure was measured by an examining physician using a standard mercury sphygmomanometer with a 14-cm cuff. With the subject seated, systolic blood pressure and fifth-phase diastolic blood pressure were measured in each arm to the nearest 2 mm Hg. The average systolic and diastolic blood pressures in both arms were used for analysis. Cigarette smoking status (current, former, never) was determined by a trained interviewer. Current smokers were defined as men who smoked one or more cigarettes daily. Weight and height were measured with the participants wearing only socks and underpants. Body mass index (weight/height2) was then calculated. Alcohol drinking habits were ascertained from responses to the Cornell Medical Index ("Do you usually take two or more alcoholic drinks per day?" Yes/No). Similar examinations were repeated every 3 to 5 years. The data were supplemented by information on cardiovascular illness from hospital records.
The subjects for the current study were a subgroup of 2271 men in the Normative Aging Study. Seven men were excluded because of incomplete baseline information on the Cornell Medical Index. In addition, two men were excluded because they had possible coronary heart disease at baseline. All exposures were assessed prospectively (ie, before the onset of coronary heart disease).
Assessment of Morbidity and Mortality
We used a case-control design nested within a prospective epidemiologic study. The cases in our study consisted of 402 men who developed incident coronary heart disease between the baseline exam and March 1993. The diagnostic categories of coronary heart disease under consideration include nonfatal myocardial infarction (n=137), angina pectoris (n=134), and CHD deaths (n=131). The criteria for myocardial infarction and angina pectoris were those used in the Framingham Heart Study. 16 Myocardial infarction was diagnosed only when documented by unequivocal electrocardiographic changes (ie, pathologic Q waves), by a diagnostic elevation of serum enzymes (serum glutamic-oxaloacetic transaminase and lactic dehydrogenase) together with chest discomfort consistent with myocardial infarction, or by autopsy. Angina pectoris was diagnosed when the subject reported recurrent chest discomfort lasting up to 15 minutes, which was distinctly related to exertion or excitement and was relieved by rest or nitroglycerin. Death from coronary heart disease was designated when a death certificate (coded according to the Eighth Revision of the International Classification of Diseases17) indicated an underlying cause of death coded to rubric 410-414. Fatal coronary heart disease was then further categorized into cases of sudden cardiac death, and nonsudden CHD deaths. Sudden cardiac death was defined as death within one hour of the onset of symptoms when no previous serious illness was reported and no other possible cause of death (other than coronary disease) was reported.
The controls in the study consisted of all subjects who remained free of coronary heart disease throughout follow-up (n= 1869). Exposure and covariate data from controls were collected at baseline in the same manner as the cases.
Data Analysis
We performed logistic regression using the Statistical Analysis System (SAS)18 to estimate age-adjusted odds ratios of coronary heart disease according to levels of anxiety. We also performed multiple logistic regression analysis, controlling for a range of potential confounding variables including: age (years); body mass index (kg/m2); smoking status (never, current, former); systolic and diastolic blood pressure (mm Hg); serum cholesterol level (mg/dL); family history of heart disease (yes/no); and two or more drinks of alcohol per day (yes/no).
Results
Of the 2271 men, 402 developed CHD over the follow-up period. Total CHD was further categorized We compared the cardiovascular disease risk factor distributions of CHD cases and control subjects ( Table  1) . As expected, CHD cases were slightly older than disease-free control subjects, had somewhat higher body mass index, higher serum cholesterol levels, and higher systolic and diastolic blood pressure levels (P<.01 for all comparisons). We adjusted for all the potential confounding variables listed in Table 1 tAdjusted for age, smoking (never, current, former), systolic and diastolic blood pressure, serum cholesterol level, family history of heart disease, and two or more drinks of alcohol per day (y/n).
95% confidence intervals in parentheses.
missing data on covariates, the numbers of cases and control subjects in the multivariate analyses are slightly less than the corresponding numbers in the age-adjusted analyses.
When we examined diagnostic categories within fatal CHD, elevated odds ratios were found for sudden cardiac death. Although based on a small number of cases, the multivariate odds ratio was 2.96 (95% CI: 1.02-8.55) for men who scored 1 on the anxiety scale compared with men who scored 0; and 4.46 (95% CI: 0.92-21.6) for men who scored 2 or higher. There appeared to be little elevation in the risk for nonsudden causes of cardiac death (Table 3) .
Discussion
There have been few epidemiologic studies of psychosocial risk factors for sudden cardiac death. Sudden death has proved to be a difficult endpoint to study using the case-control design, as investigators have been forced to make retrospective assessments of exposure from proxy respondents (since the index cases are, by definition, dead). Proxy respondents may be biased in their recall of anxiety levels in the index case. Even if it were feasible to carry out a study among "survivors" of sudden cardiac death (ie, individuals who have been resuscitated following an attack of ventricular fibrillation), it would be impossible to rule out reverse causation, in which the individual's anxiety level is raised as a result of their near-death experience. For these reasons, the association between anxiety and sudden cardiac death can only be reliably addressed using the prospective cohort design.
There now appear to be three such cohort studies - Katz et a19 studied 38 patients with frequent premature ventricular beats (VPBs) (defined as more than 30 per hour) and found that they scored higher compared with an ageand sex-matched control group on several standardized instruments that measured levels of anxiety. Patients with frequent VPBs described themselves as "frightened, desperate, fearful, nervous," and more "tense, anxious, agitated, high strung, and jumpy."9
Diminished heart rate variability has been identified as a potent risk marker for sudden cardiac death in patients recovering from myocardial infarction,22-24 as well as in apparently healthy subjects.25,26 Recent evidence suggests that patients who are "highly anxious" on the Minnesota Multiphasic Personality Inventory,27 as well as DSM-III-R defined panic disorder patients,28,29 exhibit reduced heart rate variability compared to control subjects. Such findings suggest that individuals with severe anxiety may exhibit pathological alterations in cardiac autonomic control, which may place them at higher risk of ventricular arrhythmia and sudden cardiac death.
One limitation of our data is that they are based on small numbers of sudden death, resulting in imprecise estimates of risk. However, the magnitude and specificity of the association are quite consistent across the three cohort studies that have been reported to date.4,5 All three studies adjusted for a wide range of potential confounding factors in assessing the relationship of anxiety to risk of fatal CHD. Nonetheless, it is possible that some unmeasured confounding factor, such as diet or physical exercise, could explain the observed association. On the other hand, the specificity of the association between anxiety and sudden death makes confounding an unlikely explanation for the observed effect. If confounding by diet or exercise could explain the association, one would have expected a positive relationship of anxiety to nonfatal myocardial infarction, as well as to fatal CHD. In fact, the association was specific to fatal CHD (in particular to sudden cardiac death) in all three cohort studies. Finally, the magnitude of the observed association (relative risks ranging between 2.5 to 6) makes residual confounding unlikely to account for the findings.
In the present study, assessment of anxiety was made only once, at baseline. The average time to onset of myocardial infarction or angina was 15.3 years (SD, 6.7 years), and the average time to occurrence of sudden cardiac death was 17.5 years (SD, 8.3 years). It is possible that a proportion of subjects who were normal at baseline may have developed symptoms of anxiety during the interval leading up to the occurrence of coronary endpoints. This is likely to have introduced nondifferential misclassification with respect to exposure (anxiety) status, and therefore biased our results in the direction towards the null.
All three cohort studies to date have been based in male populations.4'5 To the extent that anxiety and panic disorders are more common in women,30 there is an urgent need for studies to be carried out in women. We are currently investigating this association in two separate cohorts representing over 200 000 women.
Finally, more information needs to be gathered on the psychological and psychiatric profiles of patients at risk of sudden cardiac death. Anxiety disorders are classified by DSM-III-R30 into four major categories: panic disorder with and without agoraphobia, social phobia and other phobias (eg, simple phobia and agoraphobia without a history of panic attacks), generalized anxiety disorder, and obsessive compulsive disorder. In the present study, we relied on selfreports of anxiety symptoms, and made no further attempts to collect data to verify clinical diagnoses. We are, however, currently planning to carry out a study to collect such data from Normative Aging Study participants.
